30.03.2015 17:04:51
|
Perrigo Closes 3.8 Bln Euro Acquisition Of Omega Pharma Invest - Quick Facts
(RTTNews) - Drugmaker Perrigo Co. plc (PRGO) announced that it has completed the acquisition of Belgian OTC healthcare company Omega Pharma Invest N.V. in a cash and stock deal valued at about 3.8 billion euros, including assumed debt of 1.3 billion euros from Marc Coucke, Waterland Private Equity Fund V CV and co-investors of Waterland.
The deal was agreed upon in early November 2014, and was expected to close in the first quarter of calendar year 2015.
Perrigo expects the deal to be immediately accretive and between $0.10 and $0.20 accretive to fiscal 2016 adjusted earnings per share after adjusting for amortization, transaction and financing costs.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Perrigo Companymehr Nachrichten
Keine Nachrichten verfügbar. |